Found 52 matching trials
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants EARLY_PHASE1 The purpose of this study is to assess the safety, tolerability, and effica...
Show More Location
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology
Learn More & Join Trial
A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia PHASE1 Patients with relapsed leukemia often develop resistance to chemotherapy. F...
Show More Status
Active Not Recruiting
Location
Seattle Children's Hospital
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL PHASE1 The purpose of this study is to evaluate the safety and efficiency of allog...
Show More Location
Affiliated Hospital of Academy of Military Medical Sciences ,
Learn More & Join Trial
A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma PHASE1 This is a single-center, open-label study to evaluate the safety and effica...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus PHASE1 This is a single-center, single-arm, open-label phase 1/2 study of CART19 i...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma PHASE1 The goal of this prospective, multicentric, single-arm, phase I/II clinical...
Show More Location
Hospital de Clínicas da UNICAMP
Learn More & Join Trial
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). PHASE3 The purpose of this study is to measure the efficacy of AZD0120 compared wi...
Show More Learn More & Join Trial
A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects PHASE1 This is a single arm, single-center, non-randomized study to evaluate the s...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial